Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Adagio Medical Holdings (ADGM) posted Return on Sales of 2.31% for Q4 2025, down 244.57% sequentially from 0.67% in Q3 2025.

Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025) Analysis & Trends

Adagio Medical Holdings has reported Return on Sales for 3 years, with the latest figure at 2.31% in Q4 2025.

Quarterly Return on Sales changed N/A year-over-year to 2.31% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.31% (changed N/A YoY) and the FY2024 annual result came in at 2.35%, down 35.0% from the prior year.
Return on Sales fell to 2.31% in Q4 2025 per ADGM's latest filing, from 0.67% in the prior quarter.
Over five years, Return on Sales peaked at 0.36% in Q3 2024 and troughed at 3.68% in Q1 2024.
A 3-year average of 1.58% and a median of 1.22% in 2024 frame the typical range for Return on Sales.
The widest YoY moves for Return on Sales: up 254 bps in 2025, down 31 bps in 2025.
Over 3 years, Return on Sales stood at 0.82% in 2023, then jumped by 56 bps to 0.36% in 2024, then plunged by 540 bps to 2.31% in 2025.
According to Business Quant data, Return on Sales over the past three periods registered 2.31%, 0.67%, and 1.14% for Q4 2025, Q3 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.00%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.00%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.00%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.00%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.00%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.00%
10	Adagio Medical Holdings	14.11 Mn	14.11 Mn	-	-

Download Data